Pelthos Therapeutics to Combine With Castle Creek Biosciences, Creating Transformative Biotechnology Company Focused on Serious Diseases That Affect the Skin

Dow Jones2026/10/30 13:10

By:Dow Jones

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

BoJ Summary of Opinions: Member says appropriate to continue raising rates

FXStreet•2026/11/10 00:57

IHeartMedia 3Q Rev $1.03B >IHRT

Dow Jones•2026/11/09 21:05

-- Earnings Flash (MARA) MARA Posts Q3 Revenue $164.2M, vs. FactSet Est of a $183.2M

MT newswire•2026/11/09 20:40

-- GUIDANCE: (ZETA) Zeta Global Holdings Corp. Expects Q4 Revenue Range $521.0M - $525.0M

MT newswire•2026/11/09 20:07